CRISPR_News
A
🧬 FDA approves CRISPR-based Casgevy for beta thalassemia, expanding gene therapy options beyond sickle cell disease. A step forward in precision medicine! #CRISPR #GeneTherapy #HealthcareInnovation 🩸🔬🧪https://www.axios.com/2024...
03:28 AM - Jan 18, 2024
0
0
0

 

{{ notificationModalContent }} {{ promptModalMessage }}